These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8391107)

  • 1. [Studies on protein phosphatase 1/2A in liver cancer tissues: preliminary report].
    Sakon M; Murata K; Okuyama M; Yukawa M; Kambayashi J; Monden M; Mori T
    Nihon Geka Gakkai Zasshi; 1993 Mar; 94(3):318. PubMed ID: 8391107
    [No Abstract]   [Full Text] [Related]  

  • 2. [Expression and clinical significance of telomerase hTRT in primary hepatocellular carcinoma].
    Zhou YJ; Zhang XF; Lu HS; Huang CM; Yang FD; Wang C
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):500. PubMed ID: 15329219
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biological markers in hepatocellular carcinoma].
    Deugnier Y; David V; Leray G; Blayau M; Le Gall JY
    Ann Biol Clin (Paris); 1988; 46(1):85-8. PubMed ID: 2455460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-fetoprotein and hepatocellular carcinoma.
    Colli A; Fraquelli M; Conte D
    Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detecting the gamma-glutamyltransferase mRNA-H in the peripheral blood of primary hepatocellular carcinoma patients].
    Han GQ; Qin CY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):630-1. PubMed ID: 14572351
    [No Abstract]   [Full Text] [Related]  

  • 6. Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma.
    Tang W; Miki K; Kokudo N; Sugawara Y; Imamura H; Minagawa M; Yuan LW; Ohnishi S; Makuuchi M
    Int J Oncol; 2003 May; 22(5):969-75. PubMed ID: 12684661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manifestations and prognosis of carcinoma of the liver.
    Malt RA; Van Vroonhoven TJ; Kakumoto Y
    Surg Gynecol Obstet; 1972 Sep; 135(3):361-4. PubMed ID: 4340970
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: a new candidate for early diagnosis of hepatocellular carcinoma.
    Tsutsumi M; Sakamuro D; Takada A; Zang SC; Furukawa T; Taniguchi N
    Hepatology; 1996 May; 23(5):1093-7. PubMed ID: 8621139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease.
    Qu KZ; Zhang K; Ma W; Li H; Wang X; Zhang X; Giles F; Lai M; Afdhal NH; Albitar M
    J Gastroenterol Hepatol; 2011 Apr; 26(4):751-8. PubMed ID: 21418304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum arginase activity in patients with liver cirrhosis and hepatocellular carcinoma].
    Chrzanowska A; Mielczarek-Puta M; Skwarek A; Krawczyk M; Barańczyk-Kuźma A
    Wiad Lek; 2007; 60(5-6):215-8. PubMed ID: 17966882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma. Clinical and laboratory observations.
    Hersh T; Kaldenbaugh H; Calderon M; Grubb MN; Burdine JA; Goyal RK
    Am J Gastroenterol; 1972 Aug; 58(2):162-71. PubMed ID: 4341422
    [No Abstract]   [Full Text] [Related]  

  • 12. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
    Nouso K; Urabe Y; Higashi T; Nakatsukasa H; Hino N; Ashida K; Kinugasa N; Yoshida K; Uematsu S; Tsuji T
    Cancer; 1996 Jul; 78(2):232-36. PubMed ID: 8673997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginase-1 is a novel immunohistochemical marker of hepatocellular differentiation.
    Ordóñez NG
    Adv Anat Pathol; 2014 Jul; 21(4):285-90. PubMed ID: 24911253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
    Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
    Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymidine phosphorylase activity in liver tissue and its correlation with multifocal occurrence of hepatocellular carcinomas.
    Ikeguchi M; Sakatani T; Ueda T; Hirooka Y; Kaibara N
    In Vivo; 2001; 15(4):265-70. PubMed ID: 11695216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
    Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glypican-3 immunostaining significantly improves histological diagnosis of hepatocellular carcinoma.
    Honsová E; Lodererová A; Franková S; Oliverius M; Trunecka P
    Cas Lek Cesk; 2011; 150(1):37-40. PubMed ID: 21400962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gpc-3 is a notable diagnostic, prognostic and a latent targeted therapy marker in hepatocellular carcinoma.
    Zou ZQ; Ding YP; Long B; Yuh JG; Xu AL; Lang ZW; Zou SY; Liu YD; Ding K; Li YY
    Hepatogastroenterology; 2010; 57(102-103):1285-90. PubMed ID: 21410073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocollagen proline hydroxylase in sera of Ugandans with hepatocellular carcinoma.
    Keiser HR; Vogel CL; Sadikali F
    J Natl Cancer Inst; 1972 Nov; 49(5):1251-5. PubMed ID: 4119495
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alpha-fetoprotein producing hepatocellular carcinoma, AT-III producing hepatocellular carcinoma].
    Nakamura K; Makino I
    Ryoikibetsu Shokogun Shirizu; 1995; (7):265-8. PubMed ID: 8749467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.